Tsunakuni Ikka, Taichi Hatta, Misao Fujita. Amendments to ASRM: Can we move away from a “Therapeutic Haven”?. Stem Cell Reports. 2024
Misao Fujita, Taichi Hatta, Tsunakuni Ikka, Tatsuo Onishi. The urgent need for clear and concise regulations on exosome-based interventions. Stem Cell Reports. 2024
Yohei Sobukawa, Taichi Hatta, Daito Funaki, Eiji Nakatani. Safety of Combined Statin and Fibrate Therapy: Risks of Liver Injury and Acute Kidney Injury in a Cohort Study from the Shizuoka Kokuho Database. Drugs - Real World Outcomes. 2024
Tsunakuni Ikka, Taichi Hatta, Yoko Saito, Misao Fujita. Does the Act on the Safety of Regenerative Medicine in Japan ensure “safety”?: Implications of low adverse event reporting. Stem Cell Reports. 2023
Tsutomu Sawai, Taichi Hatta, Kyoko Akatsuka, Misao Fujita. Human genome editing in clinical applications: Japanese lay and expert attitudes. Frontiers in Genetics. 2023. 14
Expanding Global Research: Adapting Mixed Methods Research to Address Culturally-Specific Asian Country Social Issues
(MMIRA Global Conference 2024 2024)
文化的背景を認識し混合研究法に組み込むことの含意
(第9回日本混合研究法学会年次大会 2023)
Application of the Cultural Narrative Framework to Mixed Methods Study in Japan
(Fifth Asia Regional Mixed Methods Conference 2023)
2021/04 - 現在 Shizuoka Graduate University of Public Health Lecturer
2018/04 - 2021/03 Kyoto University Uehiro Research Division for iPS Cell Ethics, Center for IPS Cell Research and Application Assistant Professor
2014/04 - 2018/03 Kyoto University Uehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application Research Fellow
2010/04 - 2014/03 Kyoto University Hospital Department of Clinical Innovative Medicine, Translational Research Center
Committee career (3):
2022/04 - 現在 静岡県立総合病院 臨床研究倫理委員会 外部委員
2015/01 - 現在 日本混合研究法学会 理事
2019/08 - 2022/07 Mixed Methods International Research Association Executive Board member at Large
Awards (4):
2024/03 - Shizuoka Graduate University of Public Health 2023 Most Outstanding Faculty Research Award Does the Act on the Safety of Regenerative Medicine in Japan ensure “safety”?: Implications of low adverse event reporting. Stem Cell Reports, 18(12), 2297-2299.
2023/03 - Shizuoka Graduate University of Public Health 2022 Most Outstanding Faculty Research Award Financial risks posed by unproven cell interventions: Estimation of refunds from medical expense deductions in Japan. Stem Cell Reports, 17(5), 1016-1018.
2022/08 - Mixed Methods International Research Association The MMIRA Dissertation Award (The Honorable Mention Award) Crossover Mixed Analysis in a Convergent Mixed Methods Design Used to Investigate Clinical Dialogues About Cancer Treatment in the Japanese Context. Journal of Mixed Methods Research, 14(1), 84-109.
Mixed Methods International Research Association
, THE BEHAVIORMETRIC SOCIETY
, JAPANESE ASSOCIATION OF QUALITATIVE PSYCHOLOGY
, THE JAPANESE PSYCHOLOGICAL ASSOCIATION
, JAPAN ASSOCIATION FOR BIOETHICS
, Japanese Society of Mixed Methods Research